Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cytokines in cancer immunity and immunotherapy.
Smyth MJ, Cretney E, Kershaw MH, Hayakawa Y. Smyth MJ, et al. Among authors: cretney e. Immunol Rev. 2004 Dec;202:275-93. doi: 10.1111/j.0105-2896.2004.00199.x. Immunol Rev. 2004. PMID: 15546400 Review.
Functional analysis of granzyme M and its role in immunity to infection.
Pao LI, Sumaria N, Kelly JM, van Dommelen S, Cretney E, Wallace ME, Anthony DA, Uldrich AP, Godfrey DI, Papadimitriou JM, Mullbacher A, Degli-Esposti MA, Smyth MJ. Pao LI, et al. Among authors: cretney e. J Immunol. 2005 Sep 1;175(5):3235-43. doi: 10.4049/jimmunol.175.5.3235. J Immunol. 2005. PMID: 16116214
Cancer: novel therapeutic strategies that exploit the TNF-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway.
Cretney E, Takeda K, Smyth MJ. Cretney E, et al. Int J Biochem Cell Biol. 2007;39(2):280-6. doi: 10.1016/j.biocel.2006.10.005. Epub 2006 Oct 7. Int J Biochem Cell Biol. 2007. PMID: 17097329 Review.
IL-21 enhances tumor-specific CTL induction by anti-DR5 antibody therapy.
Smyth MJ, Hayakawa Y, Cretney E, Zerafa N, Sivakumar P, Yagita H, Takeda K. Smyth MJ, et al. Among authors: cretney e. J Immunol. 2006 May 15;176(10):6347-55. doi: 10.4049/jimmunol.176.10.6347. J Immunol. 2006. PMID: 16670347
TNF-related apoptosis-inducing ligand as a therapeutic agent in autoimmunity and cancer.
Cretney E, Shanker A, Yagita H, Smyth MJ, Sayers TJ. Cretney E, et al. Immunol Cell Biol. 2006 Feb;84(1):87-98. doi: 10.1111/j.1440-1711.2005.01413.x. Immunol Cell Biol. 2006. PMID: 16405656 Review.
Cutting edge: TRAIL deficiency accelerates hematological malignancies.
Zerafa N, Westwood JA, Cretney E, Mitchell S, Waring P, Iezzi M, Smyth MJ. Zerafa N, et al. Among authors: cretney e. J Immunol. 2005 Nov 1;175(9):5586-90. doi: 10.4049/jimmunol.175.9.5586. J Immunol. 2005. PMID: 16237043
NKG2D function protects the host from tumor initiation.
Smyth MJ, Swann J, Cretney E, Zerafa N, Yokoyama WM, Hayakawa Y. Smyth MJ, et al. Among authors: cretney e. J Exp Med. 2005 Sep 5;202(5):583-8. doi: 10.1084/jem.20050994. Epub 2005 Aug 29. J Exp Med. 2005. PMID: 16129707 Free PMC article.
Activation of NK cell cytotoxicity.
Smyth MJ, Cretney E, Kelly JM, Westwood JA, Street SE, Yagita H, Takeda K, van Dommelen SL, Degli-Esposti MA, Hayakawa Y. Smyth MJ, et al. Among authors: cretney e. Mol Immunol. 2005 Feb;42(4):501-10. doi: 10.1016/j.molimm.2004.07.034. Mol Immunol. 2005. PMID: 15607806 Review.
The second pathway involves the engagement of death receptors (e.g. Fas/CD95) on target cells by their cognate ligands (e.g. ...
The second pathway involves the engagement of death receptors (e.g. Fas/CD95) on target cells by their cognate ligands (e.g. . …
NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer.
Smyth MJ, Swann J, Kelly JM, Cretney E, Yokoyama WM, Diefenbach A, Sayers TJ, Hayakawa Y. Smyth MJ, et al. Among authors: cretney e. J Exp Med. 2004 Nov 15;200(10):1325-35. doi: 10.1084/jem.20041522. J Exp Med. 2004. PMID: 15545356 Free PMC article.
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.
Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ. Cretney E, et al. J Immunol. 2002 Feb 1;168(3):1356-61. doi: 10.4049/jimmunol.168.3.1356. J Immunol. 2002. PMID: 11801676
45 results
Jump to page
Feedback